"Research studies (including aircraft simulations) show no evidence to support airborne transmission of nut allergens as a ...

Patients with inflammatory bowel disease (IBD) who initially responded to the investigational monoclonal antibody ...

Glaub and Ford worked together at Afferent Pharmaceuticals Inc., where Glaub was CEO and Ford chief scientific officer. Their ...

Effective treatment with dupilumab may allow younger children with severe atopic dermatitis and short stature to catch up on ...

The potential blockbuster drug was approved by the agency more than a month before its scheduled decision date. A potential ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...

The FDA also approved the FoundationOne Liquid CDx assay to identify patients who qualify for the newly approved treatment.

Data from the Rainbowfish trial was presented at the World Muscle Society (WMS) Congress 2024 in Prague, Czech Republic.

Swiss drug makers Lonza and Roche agreed in March to the sale the Vacaville campus in the heart of Solano County’s burgeoning ...

Just in the first half of 2024, over $1.7 billion was committed to autoimmune disease research. The influx is driven largely ...

Jasper Therapeutics, a biotech looking to make stem cell transplants less taxing and to treat immune-mediated diseases, ...

The Food and Drug Administration (FDA) approved Genentech's Itovebi (inavolisib), in combination with palbociclib (Ibrance) ...